Aloran Mazumder

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Martinostat as a novel HDAC inhibitor to overcome tyrosine kinase inhibitor resistance in chronic myeloid leukemia.

Martinostat as a novel HDAC inhibitor to overcome tyrosine kinase inhibitor resistance in chronic myeloid leukemia.

Journal: Clinical epigenetics
Published: April 25, 2025

Aberrant cytoplasmic localization of MLH1 characterizes a cell population that seeds breast cancer recurrence.

Aberrant cytoplasmic localization of MLH1 characterizes a cell population that seeds breast cancer recurrence.

Journal: Nature communications
Published: November 26, 2024

Dual inhibition of sirtuins 1 and 2: reprogramming metabolic energy dynamics in chronic myeloid leukemia as an immunogenic anticancer strategy.

Dual inhibition of sirtuins 1 and 2: reprogramming metabolic energy dynamics in chronic myeloid leukemia as an immunogenic anticancer strategy.

Journal: Cancer communications (London, England)
Published: January 04, 2024

Molecular portraits of cell cycle checkpoint kinases in cancer evolution, progression, and treatment responsiveness.

Molecular portraits of cell cycle checkpoint kinases in cancer evolution, progression, and treatment responsiveness.

Journal: Science advances
Published: June 30, 2023

Marine Polyether Phycotoxin Palytoxin Induces Apoptotic Cell Death via Mcl-1 and Bcl-2 Downregulation.

Marine Polyether Phycotoxin Palytoxin Induces Apoptotic Cell Death via Mcl-1 and Bcl-2 Downregulation.

Journal: Marine drugs
Published: March 08, 2023

Endocannabinoid dysfunction in neurological disease: neuro-ocular DAGLA-related syndrome.

Endocannabinoid dysfunction in neurological disease: neuro-ocular DAGLA-related syndrome.

Journal: Brain : a journal of neurology
Published: April 16, 2022

Raloxifene Suppresses Tumor Growth and Metastasis in an Orthotopic Model of Castration-Resistant Prostate Cancer.

Raloxifene Suppresses Tumor Growth and Metastasis in an Orthotopic Model of Castration-Resistant Prostate Cancer.

Journal: Biomedicines
Published: March 15, 2022

The DNA damage repair landscape in Black women with breast cancer.

The DNA damage repair landscape in Black women with breast cancer.

Journal: Therapeutic advances in medical oncology
Published: July 16, 2021

HER2 Activation and Endocrine Treatment Resistance in HER2-negative Breast Cancer.

HER2 Activation and Endocrine Treatment Resistance in HER2-negative Breast Cancer.

Journal: Endocrinology
Published: June 15, 2021

Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer.

Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer.

Journal: Nature communications
Published: September 15, 2020

The HDAC6 inhibitor 7b induces BCR-ABL ubiquitination and downregulation and synergizes with imatinib to trigger apoptosis in chronic myeloid leukemia.

The HDAC6 inhibitor 7b induces BCR-ABL ubiquitination and downregulation and synergizes with imatinib to trigger apoptosis in chronic myeloid leukemia.

Journal: Pharmacological research
Published: November 10, 2019

Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells.

Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells.

Journal: Clinical epigenetics
Published: October 25, 2019
Showing 1-12 of 29

Last Updated: 09/26/2026